ACbeta (PF3D7_0802600) is an adenylyl cyclase that synthesizes cAMP during the P. falciparum erythrocytic stage and is essential for erythrocyte invasion (PMID:22761895, PMID:31075098). The recombinant enzyme is pH-dependent and can be blocked by small-molecule inhibitors, one of which is selective for ACbeta over human soluble adenylyl cyclase and kills intraerythrocytic parasites (PMID:22761895). Conditional genetic disruption established that ACbeta-derived cAMP is specifically required at the invasion step, while earlier developmental stages proceed in its absence; the cAMP signal acts through PKA, which phosphorylates the cytoplasmic domain of AMA1 as one defined effector of invasion (PMID:31075098). A bicarbonate-sensitive cytoplasmic adenylyl cyclase activity consistent with ACbeta is activated in merozoites by low-K+ (plasma-like) conditions, raising cytosolic cAMP to drive PKA activation and microneme secretion, with cAMP also feeding a Ca2+-regulating Epac pathway (PMID:25522250). In the related apicomplexan Toxoplasma gondii, the ACbeta ortholog localizes to a rhoptry subcompartment in an AIP-dependent manner, and conservation of the ARO interaction network in P. falciparum implies a similar localization mechanism (PMID:26769898). Beyond these findings, no further mechanistic detail for PF3D7_0802600 has been characterized in the available corpus.